Eating Disorder Clinical Trials 2024

Eating Disorder Clinical Trials 2024

Eating Disorder research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in eating disorder clinical trials today.

Eating Disorder Clinical Trials

Here are the 6 most popular medical studies for eating disorder

Ottawa, Ontario

Behavioral Intervention

Group Psychodynamic Interpersonal Psychotherapy for Binge Eating Disorder

Recruiting1 award6 criteria
Ottawa, Ontario

Binge Eating Disorder (BED) affects as many as 3% of women and men in Ontario, 8% of obese individuals, and 30% to 50% of those participating in weight loss programs. BED, the most common eating disorder, is characterized by over-eating with loss of control (i.e., binge eating), but with no purging (e.g., vomiting).Our previous research indicates that the total health care costs for women with BED is 36% higher than the Canadian average for women of a similar age, and that health care costs significantly decreased following intensive treatment at our Centre. The main goal of our study is to inform the development of a stepped care approach to the treatment of BED. Stepped care involves providing easily accessible low intensity treatment first, and then providing more expensive intensive treatment second, if necessary. The second goal is to assess if a second more intensive step of treatment provides added value. Although stepped care for BED is suggested by a number of clinicians and researchers, no study adequately tests predictors of who might benefit from minimal treatment alone and who would require the more intensive second step. The results of this study will guide decision making regarding who benefits from stepped care, and will help to increase the accessibility, availability, and cost effectiveness of psychological treatments for BED.

Popular filter options for eating disorder trials

Anorexia Nervosa Clinical Trials

View 32 Anorexia Nervosa medical studies.

ED Clinical Trials

View 31 ED medical studies.

Eating Disorder Clinical Trials With No Placebo

View 50 eating disorder medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to eating disorder

What are the top hospitals conducting eating disorder research?

In the realm of eating disorders, several hospitals are making significant strides in clinical trials to better understand and treat these complex conditions. In New york, the Department of Psychiatry's Eating and Weight Disorders Program is leading the way with three ongoing trials focused on eating disorders. While they may not have any completed studies to their name just yet, their dedication to research shows promise for future breakthroughs. Similarly, at Yale's Department of Psychiatry in New Haven, researchers are actively conducting three clinical trials centered around eating disorders but also lack any past records of completed studies.

Philadelphia's Drexel University takes part in this pursuit as well with two active eating disorder trials being carried out at Stratton Hall. With no all-time trial data available either, it is evident that cutting-edge research is underway at this institution. Meanwhile, at Lindner Center of HOPE in Mason another renowned facility dedicated to mental health care shares a similar focus by currently engaging in two ongoing clinical investigations within the realm of eating disorders.

Lastly but certainly not least Mayo Clinic located in Rochester has demonstrated its commitment through an active trial and a notable milestone—their first recorded eating disorder study took place back 2012 marking their initiation into this field. These institutions collectively showcase an unwavering dedication to unraveling the complexities surrounding various types of disordered eating behaviors prevalent among many individuals today.

These hospitals play a vital role in advancing our understanding and treatment options for those affected by these challenging conditions. Through collaboration between medical professionals and patients participating in these groundbreaking trials we hope to see innovative approaches emerge that will ultimately enhance quality of life for countless individuals grappling with debilitating effects associated with eating disorders while bridging path towards brighter future

Which are the best cities for eating disorder clinical trials?

When it comes to eating disorder clinical trials, several cities offer opportunities for individuals seeking innovative treatments and interventions. Boston, Massachusetts, stands out with 4 active trials exploring TNX-1900, Cognitive Behavioral Therapy (CBT), the Diabetes Body Project, and more. New York City also offers 4 ongoing studies focusing on participants without Bulimia Nervosa, Parent Education and Patient Coaching, Interoceptive Exposure Treatment (IE), among others. Providence, Rhode island, boasts 3 active trials centered around Family-Based Treatment and iACT Experimental Intervention. In Hamilton, Ontario there are 3 active trials involving a Support Group for Caregivers and Self-Compassionate Letter-Writing Intervention. Lastly, New Haven in Connecticut has 3 active trials investigating LDX and Naltrexone/Bupropion as potential treatment options. These cities provide promising avenues for those interested in participating in cutting-edge research aimed at improving outcomes for individuals with eating disorders.

Which are the top treatments for eating disorder being explored in clinical trials?

Clinical trials are uncovering promising treatment options for eating disorders, offering hope for those affected by these conditions. Leading the way is Cognitive-Behavioral Therapy (CBT), a widely-studied approach that helps individuals address unhealthy thoughts and behaviors associated with their eating disorder. Another key player in clinical trials is Family-Based Treatment (FBT), which involves families actively participating in therapy to support their loved one's recovery process. Additionally, researchers are exploring the potential benefits of Dialectical Behavior Therapy (DBT), focusing on developing skills to regulate emotions and improve interpersonal relationships as part of the treatment process for eating disorders.

What are the most recent clinical trials for eating disorder?

Recent clinical trials offer hope in the field of eating disorders, with potential advancements in treatment and support. One such trial is TNX-1900, a Phase 2 study that investigates its effectiveness in addressing eating disorders. Additionally, Naltrexone Hydrochloride has shown promise as it progresses through Phase 2 and 3 trials to evaluate its efficacy for treating these conditions. Psychotherapy also remains an important avenue being explored through Phase 2 trials, aiming to enhance therapeutic interventions. Although Solriamfetol's Phase 4 trial concluded earlier, it still holds relevance due to its potential impact on managing eating disorders. Lastly, research into the combined effects of Morning Light Version and Melatonin offers valuable insights during their ongoing Phases 1 and 2 studies. These clinical trials represent significant strides towards improving outcomes for individuals affected by eating disorders.

What eating disorder clinical trials were recently completed?

Recently, several clinical trials focused on eating disorders have reached completion, showcasing advancements in this critical area of research. Ongoing efforts to better understand and treat these complex conditions are yielding promising results. Notably, a trial investigating the effectiveness of a new therapy for anorexia nervosa concluded successfully, marking significant progress towards improved treatment options. Another study exploring innovative interventions for binge eating disorder also reached completion recently, highlighting the commitment to finding effective strategies for individuals affected by this condition. These completed trials provide hope and inspire further exploration into understanding and addressing eating disorders more effectively.